Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Glossary

The Paul-Ehrlich-Institut has developed the definitions in this glossary to help users understand regulatory and biomedical terminology. Definitions may differ from those given in German and European Union legislation and medicine. Many definitions correspond to the glossary entries on the pages of the European Medicines Agency (EMA).

ICMRA – International Coalition of Medicines Regulatory Agencies

The International Coalition of Medicines Regulatory Agencies (ICMRA) is a voluntary coalition of medicines authorities from all regions of the world that is working to ensure global access to safe, effective and high-quality medicines. The Paul-Ehrlich-Institut is a member of ICMRA.

Updated: 12.04.2023

Immune Modulator

Immunomodulators are drugs that affect the immune system. They can have a stimulating effect, ie boost the immune defense or suppress the body's immune system (immune suppression).

Updated: 21.11.2019

IQWIG - Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen

The "Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWIG, Institute for Quality and Efficiency in Health Care) is a professionally independent scientific institute. Among other things, the G-BA and the Federal Ministry of Health commission IQWIG to compare pharmaceuticals with each other. The aim is to provide the public with information about the benefits, quality and efficiency of medical services.

Updated: 25.05.2023